2023業績

2023年1月

  1. RNA Dysmetabolism and Repeat-Associated Non-AUG Translation in Frontotemporal Lobar Degeneration/Amyotrophic Lateral Sclerosis due to C9orf72 Hexanucleotide Repeat Expansion.
    Mori K, Gotoh S, Uozumi R, Miyamoto T, Akamine S, Kawabe Y, Tagami S, Ikeda M.
    JMA J. 2023 Jan 16;6(1):9-15.
  2. An international consensus statement on the benefits of reframing aging and mental health conditions in a culturally inclusive and respectful manner.
    Peisah C, de Mendonça Lima CA, Ayalon L, Banerjee D, De Leo D, Hwang TJ, Ikeda M, Jeste D, Leon T, Wang H, Warner J, Rabheru K.
    Int Psychogeriatr. 2023 Jan;35(1):13-16.
  3. Precise Discrimination for Multiple Etiologies of Dementia Cases Based on Deep Learning with Electroencephalography.
    Hata M, Watanabe Y, Tanaka T, Awata K, Miyazaki Y, Fukuma R, Taomoto D, Satake Y, Suehiro T, Kanemoto H, Yoshiyama K, Iwase M, Ikeda S, Nishida K, Takekita Y, Yoshimura M, Ishii R, Kazui H, Harada T, Kishima H, Ikeda M, Yanagisawa T.
    Neuropsychobiology. 2023 Jan 19:1-10.
  4. Characteristics of very late-onset schizophrenia-like psychosis classified with the biomarkers for Alzheimer's disease: a retrospective cross-sectional study.
    Satake Y, Kanemoto H, Taomoto D, Suehiro T, Koizumi F, Sato S, Wada T, Matsunaga K, Shimosegawa E, Gotoh S, Mori K, Morihara T, Yoshiyama K, Ikeda M.
    Int Psychogeriatr. 2023 Jan 30:1-14.

2023年2月

  1. Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly.
    Igarashi A, Sakata Y, Azuma-Kasai M, Kamiyama H, Kawaguchi M, Tomita K, Ishii M, Ikeda M.
    J Alzheimers Dis. 2023;91(4):1447-1458.

2023年3月

  1. EEG resting-state networks in Alzheimer's disease associated with clinical symptoms.
    Aoki Y, Takahashi R, Suzuki Y, Pascual-Marqui RD, Kito Y, Hikida S, Maruyama K, Hata M, Ishii R, Iwase M, Mori E, Ikeda M.
    Sci Rep. 2023 Mar 9;13(1):3964.
  2. APLP2 is predominantly cleaved by β-secretase and γ-secretase in the human brain.
    Yanagida K, Maruyama R, Tagami S, Kudo T, Okochi M, Fukumori A.
    Psychogeriatrics. 2023 Mar;23(2):311-318.

2023年4月

  1. Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies.
    Watanabe H, Hikida S, Ikeda M, Mori E.
    Front Neurol. 2023 Apr 3;14:1128566.
  2. Relationships between respiratory and oromotor events differ between motor phenotypes in patients with obstructive sleep apnea.
    Okura M, Kato T, Mashita M, Muraki H, Sugita H, Ohi M, Taniguchi M.
    Front Neurol 14:1150477-1150477,2023.

2023年5月

  1. Initial symptoms of early-onset dementia in Japan: nationwide survey.
    Edahiro A, Okamura T, Arai T, Ikeuchi T, Ikeda M, Utsumi K, Ota H, Kakuma T, Kawakatsu S, Konagaya Y, Suzuki K, Tanimukai S, Miyanaga K, Awata S.
    Psychogeriatrics. 2023 May;23(3):422-433. 2023 Feb 22.
  2. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
    Taminato T, Takeuchi T, Ueyama M, Mori K, Ikeda M, Mochizuki H, Nagai Y.
    Hum Mol Genet. 2023 May 5;32(10):1673-1682.
  3. Communication-related experiences of individuals in the early phase of semantic dementia and their families: an interview study.
    Shiba T, Yamakawa M, Endo Y, Komori K, Umezaki K, Takeya Y, Shigenobu K, Tanimukai S.
    Psychogeriatrics. 2023 May;23(3):466-474.

2023年6月

  1. Criteria for detection of possible risk factors for mental health problems in undergraduate university students.
    Ishimaru D, Adachi H, Mizumoto T, Erdelyi V, Nagahara H, Shirai S, Takemura H, Takemura N, Alizadeh M, Higashino T, Yagi Y, Ikeda M.
    Front Psychiatry. 2023 Jun 29;14:1184156.
  2. Impact of individual factors and personality trait on psychological problems of family members living with staff of a COVID-19 frontline hospital: A cross-sectional self-administered anonymous questionnaire survey.
    Uenishi S, Buyo M, Sato S, Kojitani H, Odachi R, Matsuoka T, Okuda Y, Kimoto S, Hironishi M, Takahashi S.
    Psychiatry and Clinical Neuroscience Report 2(2): e110, 2023.
  3. Editorial: Neuromodulation in basic, translational and clinical research in psychiatry, volume II.
    Jann K, Ishii R, Takahashi S, Ikeda S.
    Frontiers in Human Neuroscience 17:1212625, 2023.

2023年7月

  1. FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD.
    Fujino Y, Ueyama M, Ishiguro T, Ozawa D, Ito H, Sugiki T, Murata A, Ishiguro A, Gendron T, Mori K, Tokuda E, Taminato T, Konno T, Koyama A, Kawabe Y, Takeuchi T, Furukawa Y, Fujiwara T, Ikeda M, Mizuno T, Mochizuki H, Mizusawa H, Wada K, Ishikawa K, Onodera O, Nakatani K, Petrucelli L, Taguchi H, Nagai Y.
    elife. 2023 Jul 18;12:RP84338.
  2. Aspects of degradation and translation of the expanded C9orf72 hexanucleotide repeat RNA.
    Mori K, Gotoh S, Ikeda M.
    J Neurochem. 2023 Jul;166(2):156-171.
  3. Comparison of caregiver burden between dementia with Lewy bodies and Alzheimer's disease.
    Yuuki S, Hashimoto M, Koyama A, Matsushita M, Ishikawa T, Fukuhara R, Honda K, Miyagawa Y, Ikeda M, Takebayashi M.
    Psychogeriatrics. 2023 Jul;23(4):682-689. Epub 2023 Jun 4.
  4. Discrimination in the clinical diagnosis between patients with schizophrenia and healthy controls using eye movement and cognitive functions.
    Okazaki K, Miura K, Matsumoto J, Hasegawa N, Fujimoto M, Yamamori H, Yasuda Y, Makinodan M, Hashimoto R.
    Psychiatry and clinical neurosciences 77(7):393-400, 2023.07.01.

2023年8月

  1. A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy.
    Mori K, Shigenobu K, Beck G, Uozumi R, Satake Y, Suzuki M, Kondo S, Gotoh S, Yonenobu Y, Kawai M, Suzuki Y, Saito Y, Morii E, Hasegawa M, Mochizuki H, Murayama S, Ikeda M.
    Acta Neuropathol Commun. 2023 Aug 10;11(1):130.
  2. Report on the 1st and 2nd Japan Young Psychiatrists Organization Online International Networking Meetings (JOIN meetings) in 2021 and 2022.
    Kawagishi R, Kuramochi I, Satake Y, Masuda M, Iriki A, Imagawa H, Shimizu T, Aki M, Oya N, Norman Sartorius.
    Asian Journal of Psychiatry, 86, 2023.
  3. Subcortical volumetric alterations in four major psychiatric disorders: a mega-analysis study of 5604 subjects and a volumetric data-driven approach for classification.
    Okada N, Fukunaga M, Miura K, Nemoto K, Matsumoto J, Hashimoto N, Kiyota M, Morita K, Koshiyama D, Ohi K, Takahashi T, Koeda M, Yamamori H, Fujimoto M, Yasuda Y, Hasegawa N, Narita H, Yokoyama S, Mishima R, Kawashima T, Kobayashi Y, Sasabayashi D, Harada K, Yamamoto M, Hirano Y, Itahashi T, Nakataki M, Hashimoto R, Tha K, Koike S, Matsubara T, Okada G, van Erp T, Jahanshad N, Yoshimura R, Abe O, Onitsuka T, Watanabe Y, Matsuo K, Yamasue H, Okamoto Y, Suzuki M, Turner J, Thompson P, Ozaki N, Kasai K, Hashimoto R.
    Molecular psychiatry, online ahead of print. 2023.08.04.
  4. Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5549 individuals.
    Matsumoto J, Fukunaga M, Miura K, Nemoto K, Okada N, Hashimoto N, Morita K, Koshiyama D, Ohi K, Takahashi T, Koeda M, Yamamori H, Fujimoto M, Yasuda Y, Ito S, Yamazaki R, Hasegawa N, Narita H, Yokoyama S, Mishima R, Miyata J, Kobayashi Y, Sasabayashi D, Harada K, Yamamoto M, Hirano Y, Itahashi T, Nakataki M, Hashimoto R, Tha K K, Koike S, Matsubara T, Okada G, Yoshimura R, Abe O, van Erp T G M, Turner J A, Jahanshad N, Thompson P M, Onitsuka T, Watanabe Y, Matsuo K, Yamasue H, Okamoto Y, Suzuki M, Ozaki N, Kasai K, Hashimoto R.
    Molecular psychiatry, online ahead of print. 2023.08.18.
  5. Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.
    Kodaka F, Ohi K, Yasuda Y, Fujimoto M, Yamamori H, Hasegawa N, Ito S, Fukumoto K, Matsumoto J, Miura K, Yasui-Furukori N, Hashimoto R.
    The international journal of neuropsychopharmacology, 26(8):557-565, 2023.08.29.
  6. An international research agenda for clozapine-resistant schizophrenia.
    Luykx JJ, Gonzalez-Diaz JM, Guu TW, van der Horst MZ, van Dellen E, Boks MP, Guloksuz S, DeLisi LE, Sommer IE, Cummins R, Shiers D, Lee J, Every-Palmer S, Mhalla A, Chadly Z, Chan SKW, Cotes RO, Takahashi S, Benros ME, Wagner E, Correll CU, Hasan A, Siskind D, Endres D, MacCabe J, Tiihonen J.
    Lancet Psychiatry 10(8):644-652, 2023.

2023年9月

  1. The NIA-AA revised clinical criteria for Alzheimer's disease: are they too advanced?
    Bianchetti A, Ikeda M, Mateos R, Mondini S, Rabheru K, Serrati C, De Leo D.
    Int Psychogeriatr. 2023 Sep 27:1-3.Epub ahead of print.
  2. Effect of sleep report feedback using information and communication technology combined with health guidance on improving sleep indicators in community-dwelling older people: a pilot trial.
    Mo W, Yamakawa M, Takahashi S, Liu X, Nobuhara K, Kurakami H, Takeya Y, Ikeda M.
    Psychogeriatrics. 2023 Sep;23(5):763-772.
  3. Questionnaire survey of satisfaction with medication for five symptom domains of dementia with Lewy bodies among patients, their caregivers, and their attending physicians.
    Toya S, Manabe Y, Hashimoto M, Yamakage H, Ikeda M.
    Psychogeriatrics. 2023 Sep;23(5):752-762.
  4. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
    Kanemoto H, Mori E, Tanaka T, Suehiro T, Yoshiyama K, Suzuki Y, Kakeda K, Wada T, Hosomi K, Kishima H, Kazui H, Hashimoto M, Ikeda M.
    Int Psychogeriatr. 2023 Sep;35(9):509-517.
  5. Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
    Fukuda H, Kanzaki H, Murata F, Maeda M, Ikeda M.
    J Alzheimers Dis. 2023;95(4):1559-1572.
  6. The pros and cons of virtual networking events: online exploratory survey of psychiatrists' opinions.
    Satake Y, Kuramochi I, Kawagishi R, Masuda M, Aki M, Oya N.
    BJPsych International, FirstView. 2023.
  7. Longitudinal characteristics of insight and clinical factors in patients with schizophrenia.
    Sakai Y, Ito S, Matsumoto J, Yasuda Y, Yamamori H, Fujimoto M, Hasegawa N, Ishimaru K, Miura K, Hashimoto R.
    Neuropsychopharmacology reports, 43(3):373-381, 2023.09.12.

2023年11月

  1. Development of postoperative delirium prediction models in patients undergoing cardiovascular surgery using machine learning algorithms.
    Nagata C, Hata M, Miyazaki Y, Masuda H, Wada T, Kimura T, Fujii M, Sakurai Y, Matsubara Y, Yoshida K, Miyagawa S, Ikeda M, Ueno T.
    Sci Rep. 2023 Nov 30;13(1):21090.
  2. Social robot for older adults with cognitive decline: a preliminary trial.
    Figueroa D, Yamazaki R, Nishio S, Maalouly E, Nagata Y, Satake Y, Yamakawa M, Suzuki M, Kanemoto H, Ikeda M, Ishiguro H.
    Front Robot AI. 2023 Nov 24;10:1213705.
  3. Cerebrospinal fluid amyloid beta with amyloid positron emission tomography concordance rates in a heterogeneous group of patients including late-onset psychotic disorders: a retrospective cross-sectional study.
    Satake Y, Kanemoto H, Gotoh S, Akamine S, Suehiro T, Matsunaga K, Shimosegawa E, Yoshiyama K, Morihara T, Mori K, Ikeda M.
    Psychogeriatrics. 2023 Nov;23(6):1091-1093.
  4. Complex cases with suspected dementia in the community need psychiatric support: Results from a nationwide survey in Japan.
    Satake Y, Taomoto D, Suzuki M, Shigenobu K, Kanemoto H, Yoshiyama K, Ikeda M.
    Asian J Psychiatr. 2023 Nov 20;91:103840.
  5. Normalized Power Variance: A new Field Orthogonal to Power in EEG Analysis.
    Aoki Y, Kazui H, Pascual-Marqui RD, Bruña R, Yoshiyama K, Wada T, Kanemoto H, Suzuki Y, Suehiro T, Satake Y, Yamakawa M, Hata M, Canuet L, Ishii R, Iwase M, Ikeda M.
    Clin EEG Neurosci. 2023 Nov;54(6):611-619.
  6. Predicting postoperative delirium after cardiovascular surgeries from preoperative portable electroencephalography oscillations.
    Hata M, Miyazaki Y, Nagata C, Masuda H, Wada T, Takahashi S, Ishii R, Miyagawa S, Ikeda M, Ueno T.
    Front Psychiatry. 2023 Nov 14;14:1287607.
  7. Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study.
    Lo T, Kushima I, Kimura H, Aleksic B, Okada T, Kato H, Inada T, Nawa Y, Torii Y, Yamamoto M, Kimura R, Funabiki Y, Kosaka H, Numata S, Kasai K, Sasaki T, Yokoyama S, Munesue T, Hashimoto R, Yasuda Y, Fujimoto M, Usami M, Itokawa M, Arai M, Ohi K, Someya T, Watanabe Y, Egawa J, Takahashi T, Suzuki M, Yamasue H, Iwata N, Ikeda M, Ozaki N.
    Neuropsychopharmacology reports, Online ahead of print. 2023.11.01.
  8. Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia.
    Ito S, Ohi K, Yasuda Y, Fujimoto M, Yamamori H, Matsumoto J, Fukumoto K, Kodaka F, Hasegawa N, Ishimaru K, Miura K, Yasui-Furukori N, Hashimoto R.
    Schizophrenia (Heidelberg, Germany) 9(1):78-78, 2023.11.07.

2023年12月

  1. Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan.
    Taomoto D, Sato S, Kanemoto H, Suzuki M, Hirakawa N, Takasaki A, Akimoto M, Satake Y, Koizumi F, Yoshiyama K, Takahashi R, Shigenobu K, Hashimoto M, Miyagawa T, Boeve B, Knopman D, Mori E, Ikeda M.
    Psychogeriatrics. 2023 Dec 28. Epub ahead of print.
  2. A deep learning model for the detection of various dementia and MCI pathologies based on resting-state electroencephalography data: A retrospective multicentre study.
    Watanabe Y, Miyazaki Y, Hata M, Fukuma R, Aoki Y, Kazui H, Araki T, Taomoto D, Satake Y, Suehiro T, Sato S, Kanemoto H, Yoshiyama K, Ishii R, Harada T, Kishima H, Ikeda M, Yanagisawa T.
    Neural Netw. 2023 Dec 6;171:242-250.

2023年・月不明

  1. Ribavirin treatment of severe schizophrenia with anti-Borna disease virus 1 antibodies 30 years after onset: a case report.
    Matunaga H, Fukumori A, Mori K, Morihara T, Sato S, Kitauchi K, Yanagida K, Taguchi K, Honda T, Tomonaga K.
    Case reports in psychiatry 4899364, 2023.
  2. Association Study Between White Matter Microstructure and Intelligence Decline in Schizophrenia.
    Matsumoto J, Miura K, Fukunaga M, Nemoto K, Koshiyama D, Okada N, Morita K, Yamamori H, Yasuda Y, Fujimoto M, Ito S, Hasegawa N, Watanabe Y, Kasai K, Hashimoto R.
    Clinical EEG and neuroscience, 54(6):567-573, 2021.12.10(Epub), 2023.11(published).

2023年業績として掲載する2024年刊行・online first等

  1. What happens if your colleague was the first person to notice that you have young-onset dementia?
    Edahiro A, Okamura T, Arai T, Ikeuchi T, Ikeda M, Utsumi K, Ota H, Kakuma T, Kawakatsu S, Konagaya Y, Suzuki K, Tanimukai S, Miyanaga K, Awata S.
    Geriatr Gerontol Int. 2024 Jan;24(1):176-178.